1 document found, page 1 of 1

Sort by Issue Date

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis ...

Sant'Anna, R; Gallego, P; Robinson, L; Pereira-Henriques, A; Ferreira, N; Pinheiro, F; Esperante, S; Pallares, I; Huertas, O; Almeida, M; Reixach, N

Transthyretin (TTR) is a plasma homotetrameric protein implicated in fatal systemic amyloidoses. TTR tetramer dissociation precedes pathological TTR aggregation. Native state stabilizers are promising drugs to treat TTR amyloidoses. Here we repurpose tolcapone, an FDA-approved molecule for Parkinson's disease, as a potent TTR aggregation inhibitor. Tolcapone binds specifically to TTR in human plasma, stabilizes...


1 Results

Queried text

Refine Results

Author

















Date


Document Type


Access rights


Resource


Subject